IDEXX Laboratories Inc

Healthcare · Diagnostics & Research

506.50$ -1.4% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

IDEXX Laboratories Inc (IDXX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 4,304 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IDXX
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	268	263	320	356	367	386	413	476	549	638	739	923	1,024	1,032	1,103	1,219	1,293	1,377	1,486	1,602	1,775	1,969	2,213	2,407	2,707	3,215	3,367	3,661	3,898	4,304
Cost of Revenue	103	120	142	165	171	203	220	246	270	315	360	459	494	505	525	572	594	621	670	712	800	872	972	1,041	1,136	1,326	1,363	1,471	1,519	1,644
Gross Profit	165	143	178	191	197	183	193	230	279	323	380	464	530	526	579	647	699	756	816	890	975	1,097	1,242	1,366	1,571	1,889	2,004	2,190	2,379	2,660
Research & Development	12	17	22	27	28	28	29	32	35	41	54	67	71	65	69	76	82	88	98	100	101	109	118	133	141	161	255	191	220	251
Selling, General & Administrative	95	116	111	100	96	98	41	46	50	65	82	108	116	117	127	129	138	158	174	183	207	221	245	261	301	310	326	336	442	405
Total Operating Expenses	118	148	149	145	143	127	127	150	171	208	252	327	357	350	375	410	437	489	556	582	625	684	750	813	877	957	1,106	1,093	1,251	1,300
Operating Income	47	-4.4	29	47	53	57	66	80	108	115	128	136	172	176	204	236	263	267	260	300	350	413	491	553	695	932	899	1,097	1,128	1,360
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.2	4.6	1.4	1.8	1.8	1.9	3.5	14	29	28	32	34	31	33	29	39	36	31	38
Pre-Tax Income	55	-32	-1.2	53	58	59	69	83	111	118	131	135	170	175	202	234	261	263	247	273	322	381	458	522	662	903	860	1,061	1,110	1,324
Income Tax Expense	23	-11	14	20	22	21	23	26	33	41	37	41	54	52	61	73	82	75	65	81	100	118	81	94	80	158	181	216	222	265
Net Income	33	-21	-15	33	37	38	45	57	78	78	94	94	116	122	141	162	178	188	182	192	222	263	377	428	582	745	679	845	888	1,059
EBITDA	57	10	45	64	73	79	66	80	126	140	158	177	221	226	250	284	315	321	319	370	428	496	575	641	791	1,037	1,011	1,097	1,276	1,469

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings